PD-L1 expression is a promising predictor of survival in patients with advanced lung adenocarcinoma undergoing pemetrexed maintenance therapy

Eitemau Tebyg

• Efficacy and safety of pemetrexed and nedaplatin followed by pemetrexed maintenance therapy in advanced lung adenocarcinoma
  gan: Lin, Zhong, et al.
  Cyhoeddwyd: (2017)
• PD-L1 expression indicates favorable prognosis for advanced lung adenocarcinoma patients treated with pemetrexed
  gan: Zhang, Pei, et al.
  Cyhoeddwyd: (2017)
• Alveolar rhabdomyosarcoma of nasopharynx and paranasal sinuses with metastasis to breast in a middle-aged woman: a case report and literature review
  gan: Liu, Hongmei, et al.
  Cyhoeddwyd: (2015)
• Efficacy of epidermal growth factor receptor–tyrosine kinase inhibitors for lung squamous carcinomas harboring EGFR mutation: A multicenter study and pooled analysis of published reports
  gan: Liu, Yongmei, et al.
  Cyhoeddwyd: (2017)
• Pemetrexed Alone versus Pemetrexed Combined with Oxaliplatin as Salvage Therapy 
in Stage IV Lung Adenocarcinoma
  gan: Youru LIU, et al.
  Cyhoeddwyd: (2011-09-01)